283 related articles for article (PubMed ID: 25581936)
21. TGFβ-Responsive HMOX1 Expression Is Associated with Stemness and Invasion in Glioblastoma Multiforme.
Ghosh D; Ulasov IV; Chen L; Harkins LE; Wallenborg K; Hothi P; Rostad S; Hood L; Cobbs CS
Stem Cells; 2016 Sep; 34(9):2276-89. PubMed ID: 27354342
[TBL] [Abstract][Full Text] [Related]
22. Advances in histone deacetylase inhibitors in targeting glioblastoma stem cells.
Reddy RG; Bhat UA; Chakravarty S; Kumar A
Cancer Chemother Pharmacol; 2020 Aug; 86(2):165-179. PubMed ID: 32638092
[TBL] [Abstract][Full Text] [Related]
23. Modeling the Treatment of Glioblastoma Multiforme and Cancer Stem Cells with Ordinary Differential Equations.
Abernathy K; Burke J
Comput Math Methods Med; 2016; 2016():1239861. PubMed ID: 27022405
[TBL] [Abstract][Full Text] [Related]
24. Cancer stem cells in glioblastoma.
Lathia JD; Mack SC; Mulkearns-Hubert EE; Valentim CL; Rich JN
Genes Dev; 2015 Jun; 29(12):1203-17. PubMed ID: 26109046
[TBL] [Abstract][Full Text] [Related]
25. Adhering towards tumorigenicity: altered adhesion mechanisms in glioblastoma cancer stem cells.
Turaga SM; Lathia JD
CNS Oncol; 2016 Oct; 5(4):251-9. PubMed ID: 27616054
[TBL] [Abstract][Full Text] [Related]
26. The evolving landscape of glioblastoma stem cells.
Yan K; Yang K; Rich JN
Curr Opin Neurol; 2013 Dec; 26(6):701-7. PubMed ID: 24152818
[TBL] [Abstract][Full Text] [Related]
27. The small molecule drug CBL0137 increases the level of DNA damage and the efficacy of radiotherapy for glioblastoma.
Tallman MM; Zalenski AA; Deighen AM; Schrock MS; Mortach S; Grubb TM; Kastury PS; Huntoon K; Summers MK; Venere M
Cancer Lett; 2021 Feb; 499():232-242. PubMed ID: 33253788
[TBL] [Abstract][Full Text] [Related]
28. Unexplored Functions of Sex Hormones in Glioblastoma Cancer Stem Cells.
Lee J; Troike K; Fodor R; Lathia JD
Endocrinology; 2022 Mar; 163(3):. PubMed ID: 35023543
[TBL] [Abstract][Full Text] [Related]
29. Self‑renewal signaling pathways and differentiation therapies of glioblastoma stem cells (Review).
Jin J; Grigore F; Chen CC; Li M
Int J Oncol; 2021 Jul; 59(1):. PubMed ID: 34013362
[TBL] [Abstract][Full Text] [Related]
30. Modulation of A1 and A2B adenosine receptor activity: a new strategy to sensitise glioblastoma stem cells to chemotherapy.
Daniele S; Zappelli E; Natali L; Martini C; Trincavelli ML
Cell Death Dis; 2014 Nov; 5(11):e1539. PubMed ID: 25429616
[TBL] [Abstract][Full Text] [Related]
31. The three-layer concentric model of glioblastoma: cancer stem cells, microenvironmental regulation, and therapeutic implications.
Persano L; Rampazzo E; Della Puppa A; Pistollato F; Basso G
ScientificWorldJournal; 2011; 11():1829-41. PubMed ID: 22125441
[TBL] [Abstract][Full Text] [Related]
32. Brain tumor stem cells as research and treatment targets.
Hide T; Takezaki T; Nakamura H; Kuratsu J; Kondo T
Brain Tumor Pathol; 2008; 25(2):67-72. PubMed ID: 18987831
[TBL] [Abstract][Full Text] [Related]
33. [Progress in the study of brain tumor stem cells as treatment targets].
Hide T; Kuratsu J
Brain Nerve; 2009 Jul; 61(7):781-9. PubMed ID: 19618855
[TBL] [Abstract][Full Text] [Related]
34. [The stem cell niche in glioblastoma: from fundamental aspects to targeted therapies].
Turpin A; Sharif A; Stoven L; Blond S; Maurage CA; Le Rhun É
Bull Cancer; 2015 Jan; 102(1):24-33. PubMed ID: 25609493
[TBL] [Abstract][Full Text] [Related]
35. Chemoresistance in high-grade gliomas: relevance of adenosine signalling in stem-like cells of glioblastoma multiforme.
Garrido W; Rocha JD; Jaramillo C; Fernandez K; Oyarzun C; San Martin R; Quezada C
Curr Drug Targets; 2014; 15(10):931-42. PubMed ID: 25174341
[TBL] [Abstract][Full Text] [Related]
36. Therapeutic strategies targeting glioblastoma stem cells.
Carrasco-Garcia E; Sampron N; Aldaz P; Arrizabalaga O; Villanua J; Barrena C; Ruiz I; Arrazola M; Lawrie C; Matheu A
Recent Pat Anticancer Drug Discov; 2013 Sep; 8(3):216-27. PubMed ID: 23607282
[TBL] [Abstract][Full Text] [Related]
37. Systemic approaches identify a garlic-derived chemical, Z-ajoene, as a glioblastoma multiforme cancer stem cell-specific targeting agent.
Jung Y; Park H; Zhao HY; Jeon R; Ryu JH; Kim WY
Mol Cells; 2014 Jul; 37(7):547-53. PubMed ID: 25078449
[TBL] [Abstract][Full Text] [Related]
38. PC3-Secreted Microprotein Is Expressed in Glioblastoma Stem-Like Cells and Human Glioma Tissues.
Maruyama M; Nakano Y; Nishimura T; Iwata R; Matsuda S; Hayashi M; Nakai Y; Nonaka M; Sugimoto T
Biol Pharm Bull; 2021 Jul; 44(7):910-919. PubMed ID: 33896885
[TBL] [Abstract][Full Text] [Related]
39. Elimination of cancer stem-like cells and potentiation of temozolomide sensitivity by Honokiol in glioblastoma multiforme cells.
Lai IC; Shih PH; Yao CJ; Yeh CT; Wang-Peng J; Lui TN; Chuang SE; Hu TS; Lai TY; Lai GM
PLoS One; 2015; 10(3):e0114830. PubMed ID: 25763821
[TBL] [Abstract][Full Text] [Related]
40. The interference of Notch1 target Hes1 affects cell growth, differentiation and invasiveness of glioblastoma stem cells through modulation of multiple oncogenic targets.
Cenciarelli C; Marei HE; Zonfrillo M; Casalbore P; Felsani A; Giannetti S; Trevisi G; Althani A; Mangiola A
Oncotarget; 2017 Mar; 8(11):17873-17886. PubMed ID: 28157712
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
